Cristiane D Bergerot

📢 Just published in @JNCCN ! Our RCT shows that a telehealth GA & #SuppCare Intervention (GAIN-S) improved physical function, mood & QoL in older Brazilians with metastatic cancer @WilliamDale_MD @EnriqueSoto8 @Areejmd @RyanNipp jnccn.org/view/journals/…

“Many Lung Cancers Are Now in Nonsmokers.” @nytimes tells the story of a shifting epidemic: lung cancer among people, mostly women — who’ve never smoked. The face of lung cancer is changing. 🔗 nytimes.com/2025/07/22/wel…

Bravo @JournalCancer and @AmericanCancer on this fantastic choice. @DrRanaMcKay is the real deal and the total package. cc: @UCSDCancer

Breaking news👉Glad to report the news from ph3 Contact-2 trial👉Cabozantinib + atezolizumab significantly improve outcomes in mCRPC #prostatecancer .Trial description from @ASCO TIP abstract 👇Press release: shorturl.at/cCQY4 @montypal @OncoAlert @urotoday @PCF_Science

A profound honor – this generous gift by Toby Shor is a tribute to bladder cancer patients, the care that makes survivorship possible, and the remarkable team I’m privileged to work with. @MDAndersonNews #OncSurgery @NNavai @KKBree @DrByronLee @OAlhalabiMD @DocMattCampbell…

Improve patient outcomes with integrative, evidence-backed approaches. The recent @ASCO guideline for GI cancers—developed with @Integrativeonc provides clear, research-driven guidance on therapies like mindfulness, acupuncture, and yoga. Read more 👉 ascopubs.org/doi/10.1200/ED…

Updated results from KEYNOTE-B61: First-line pembrolizumab + lenvatinib in advanced non-clear-cell RCC shows: ✅ ORR 51% ✅ CR in 8.2% ✅ Median DOR 19.5 mo A promising option for nccRCC. #oncology #kidneycancer @EUplatinum @AlbigesL @OncoAlert @Uromigos pubmed.ncbi.nlm.nih.gov/40707309/

Quality Improvement Effort With Proactive Social Worker Communication to Enhance #Palliative Care Access. ascopubs.org/doi/10.1200/OP… @ASCO @JCO_ASCO @JCOOP_ASCO #PallOnc #SuppOnc #PalliativeCare

Results from a Q-TWiST analysis of the LITESPARK-005 trial showed a trend favoring belzutifan over everolimus for patients with clear cell RCC. hubs.li/Q03yQsdB0 #KCRS2025 | #kcsm | @tompowles1 | @KidneyCAN

Congrats @NiuSanford on @NRGOncology GI-011 activated! Tagging my #GI colleagues in #LosAngeles to support enrollment. @DaniCastilloMD @gagan_brar24 @mgfakih @DrElkhoueiry @DrJZell @pashtoonkasi

A huge honor to have @UroDocAsh @MDAndersonNews visit us at @cityofhope! As we continue to grow our program, awesome to get feedback & advice from a leader in the field! @BladderCancerUS @PGrivasMDPhD @AndreaNecchi

What an amazing keynote presentation from our VP @UroDocAsh during our @CityofHope Annual GU Research Retreat organized by @MontyPal and @TDorffOnc. A visit full of inspiring discussions for future collaboration over delicious food (can always trust @ClaytonLauMD with the menu)

🚨Karie Runcie, MD joins Brian and Tom after chairing the ASCO 2025 rapid oral session to discuss the rcc/bladder presentations.  🎙️ GU Oncology Now:  buff.ly/p0ZaYRg  🍎 Apple Podcasts:   buff.ly/Q4HaH26 🎧Spotify:    buff.ly/D59ql4y

Stellar presentation by keynote speaker @UroDocAsh on bladder-sparing options in muscle-invasive disease and nuances of intermediate-risk NMIBC. 🔵 Presented at the 2nd @CityofHope_GU @cityofhope retreat, made possible by incredible team of physicians led by @WesleyYipMD…

In the July issue of The ASCO Post are highlights from the recent #ASCO25 plenary sessions, #EHA2025, #PrevConf25 as well as professional and patient reflections. Read the full issue here: ascopost.com/issues/july-25…

A big big thank you to our 4 great ASCO LDP mentors, who choose to dedicate an enormous amount of time & energy to this program. We appreciate all of their support! @montypal, @DrMarkham, Nasser Hanna & Piyush Srivastava 🙏

Can aerobic exercise help prevent brain fog caused by chemotherapy? Clinical trial reveals improved self-reported cognitive function in women with breast cancer who started an exercise program when initiating chemotherapy: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… @OncoAlert @WileyOnc_Hem #BCSM

Datos de mutaciones BRCA y HRR en #prostatecancer hormonos sensible 🧑‍🤝‍🧑 mut HRR & BRCA similres en alto & bajo volumen 📢 El impacto de BRCA/HRR parece mayor el bajo volumen ⚠️Paciente con alt-BRCA tiene peeores resutaldos con dupletes (ACT+ARSI o ADT + Docetaxel)

Sooooo excited to see our work in health equity accepted to #ASCOQLTY25! 🥳🥳🥳

Please join us in welcoming @DrRanaMcKay as our new Section Editor for Genitourinary Disease! Dr. McKay is a medical oncologist who specializes in treating people with urogenital cancers. Her research interests include precision medicine and biomarker development. @OncoAlert

To help stop cancer misinformation on social media, health care providers can participation in social networks to see the types of content to which their patients are exposed, disseminate evidence‐based information, and correct misinformation. acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca… @LoebStacy